News
I was recently at the American Red Cross to donate blood and was given interesting material on the need for Black blood ...
With an arsenal of antibody assets based on IgE, IgA, and IgG, the newly combined company has opportunities across cancer indications.
UPPSALA, Sweden, April 10, 2025 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces positive in-vivo proof-of-concept data for a powder-based intranasal vaccine candidate ...
WITH an impressive attendance of 20,522 participants from 131 countries, the European Congress of Radiology (ECR) 2025 was an ...
Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more effectively.
In the landmark Amgen v. Sanofi case (previously covered here), the Supreme Court affirmed that patent claims drawn to a genus of ...
Cullinan Therapeutics rebranded from oncology to immunology+oncology, focusing on CD19 TCEs for autoimmune diseases. Check ...
Image quality often makes the difference between an amazing multimedia experience, like feeling immersed in a high-definition ...
Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies.
A team of Northwestern University scientists spanning disciplines have developed new technology that could lead to the ...
A team of Northwestern University scientists spanning disciplines have developed new technology that could lead to the ...
New research led by Yale School of Medicine (YSM) advances the goals of creating a diagnostic test and vaccines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results